Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands, together with three urologists from Spain (Prof. Dr. Joaquín Carballido, Dr. Marc Serrallach, Dr. Félix Guerrero and Dr. David Parada, pathologist) discussed how the Bladder EpiCheck test is used in their clinical public and private practice.
PlayProf. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands, together with three urologists from Spain (Prof. Dr. Joaquín Carballido, Dr. Marc Serrallach, Dr. Félix Guerrero and Dr. David Parada, pathologist) discussed how the Bladder EpiCheck test is used in their clinical public and private practice.
A webinar by Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands and chaired by Dr. Dov Engelstein, Chairman of the Israel Association of Urology (IAU), and Dr. Ran Katz, Associate in the Israel Association of Urology (IAU).
PlayA webinar by Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands and chaired by Dr. Dov Engelstein, Chairman of the Israel Association of Urology (IAU), and Dr. Ran Katz, Associate in the Israel Association of Urology (IAU).
STAY UPDATED ON THE LATEST NEWS FROM NUCLEIX!
Go to the inbox of the email
address you just used to sign up.
Find the email sent by us. It has the subject line
“Nucleix: Please Confirm Subscription” and I
sent from “[email protected]”.
Click on the link inside the
email and you’re good to go.